Proteins may be the most important and varied biomolecules within living systems. These strings of amino acids, assuming complex 3-dimensional forms, are essential for the growth and maintenance of tissue, the initiation of thousands of biochemical reactions, and the protection of the body ... more
New tool enhances the search for genetic mutations
Concealed within the vastness of the human genome, (comprised of some 3 billion base pairs), mutations are commonplace. While the majority of these appear to have neutral effect on human health, many others are associated with diseases and disease susceptibility.
Reed Cartwright, a researcher at Arizona State University's Biodesign Institute, along with colleagues at ASU, Washington University and the Wellcome Trust Sanger Institute, Cambridge, UK, report on a new software tool known as DeNovoGear, which uses statistical probabilities to help identify mutations and more accurately pinpoint their source and their possible significance for health.
Improvements in the accuracy of mutation identification and validation could have a profound impact on the diagnosis and treatment of mutation-related diseases.
"These techniques are being considered in two different realms," Cartwright says. "The first is for pediatric diseases." Here, a child with an unusual genetic disease may undergo genomic sequencing to see if the mutations observed have been acquired from the parents or are instead, unique to the child. "We can identify these mutations and try to detect which gene may be broken," he says.
The second application is for cancer research, where tumor tissues are genetically compared with normal tissue. Many now believe that the identification of a specific cancer mutation may eventually permit clinicians to customize a treatment for that tissue type. "We are developing methods to allow researchers to make those types of analyses, using advanced, probabilistic methods," Cartwright says. "We actually model the whole process."
Indeed, the method described provides the first model-based approach for ferreting out certain types of mutations. The group's research results appear in the journal Nature Methods.
One of the primary goals in genetics is to accurately characterize genetic variation and the rate at which it occurs. Searching for DNA mutations through genetic sequencing is an important ingredient in this quest, but many challenges exist. The current study focuses on a class of mutations that play a critical role in human disease, namely de novo mutations, which arise spontaneously and are not derived from the genomes of either parent.
Traditionally, two approaches for identifying de novo mutation rates in humans have been applied, each involving estimates of average mutations over multiple generations. In the first, such rates are measured directly through an estimation of the number of mutations occurring over a known number of generations. In the second or indirect method, mutation rates are inferred by estimating levels of genetic variation within or between species.
In the new study, a novel approach is used. The strategy, pioneered in part by Donald Conrad, professor in the Department of Genetics at Washington University School of Medicine and corresponding author of the current study, takes advantage of high throughput genetic sequencing to examine whole genome data in search of de novo mutations.
"This collaboration started a few years ago, when Donald and I were both working on mutations for the 1000 genomes project," Cartwright says, referring to an ambitious project to produce a comprehensive map of human variation using next-gen sequencing.
The mutations under study may take the form of either point mutations—individual nucleotide substitutions, or so-called indel (insertion-deletion) mutations. In the latter case, single nucleotides or nucleotide sequences may be either added or subtracted from the genome.
While point mutations and indel mutations can both have adverse affects on health, indels are significantly more difficult to identify and verify. They have a strong potential to cause havoc when they occur in coding portions of the genome as the addition or deletion of nucleotides can disrupt the translation process needed to accurately assemble proteins. (The current study is the first paper to use model-based approaches to detect indel mutations.)
A seemingly simple approach to pinpointing mutations is to compare sequence data from each parent with sequence data from their offspring. Where changes exist at a given site in the offspring, de novo mutations can be inferred and their potential affect on human health, assessed.
In reality, such efforts are complicated by a number of potential sources of error, including insufficient sampling of the genome, mistakes in the gene sequencing process and errors of alignment between sequences. The new method uses a probabilistic algorithm to evaluate the likelihood of mutation at each site in the genome, comparing it with actual sequence data.
Human cells contain two copies of the genome—one from each parent. For most positions in the genome, the bases from each parent are the same or homozygous but occasionally, they are different or heterozygous.
Errors derived from conventional methods can take the form of false negatives, particularly when gene sequencing misses heterozygous sites in the genotype of the child. On the other hand, failure to identify a heterozygous site in one of the parents can lead to a false positive result.
The new method assesses the chances of an actual de novo mutation for the child in the example as very low, hence revising the false positive result (upper right panel). In the lower right panel, the new method finds a high probability for a de novo mutation, thereby revising the conventional method's false negative.
In the current study, data from the 1000 genomes project was analyzed using DeNovoGear, with markedly improved accuracy. The technique will assist ongoing efforts to better understand which mutations contribute to sporadic disease or cancer in individuals, the distribution of mutations and their characteristics across populations.
The power of this technique comes from its probabilistic model which calculates the probability of a de novo mutation at a site based on estimations of mutation rates, sequencing error rate, and the initial genetic variation in the population from which the parents arise. This model is able to consider multiple explainations for experimental observations and decide between them. The probabilities are used to indentify candidate loci which are then evaluated using target resequncing.
Given adequate data of genetic pedigree, the method is able to distinguish germline from somatic mutations in an automated manner with high accuracy. "Our goal is to develop software that will allow researchers and clinicians to estimate a range of mutation types, faster, more accurately, and cheaper," Cartwright says.
In addition to further refining the DeNovoGear software, Cartwright's group plans to more closely examine normal human tissue in order to establish rates of somatic mutation. Some of the specific mutations currently associated with cancer for example, may actually be part of normal variability, which appears to be much greater than originally assumed. "No one has really looked at this at the level we're interested in."
Arizona State University
- Washington University
- genetic mutations
- human genome
- gene sequencing
- Wellcome Trust
- genetic diseases
- gene mutations
- Arizona State University
New microscopy method offers 3D tracking of 100 single molecules at once
Since its invention over 400 years ago, the microscope has continued to evolve, peering ever deeper into nature’s mysteries at the smallest scales. In new research, Prof. Shaopeng Wang, his postdoctoral research scholar Guangzhong Ma along with their colleagues at the Biodesign Center for B ... more
X-ray eyes peer deeper into deadly pathogen
Tularemia is a rare but often lethal disease. It is caused by one of the most aggressive pathogens on earth, the bacterium Francisella tularensis. The microbe, transported by a variety of animals and insects, is able to enter and attack the body through a range of pathways, resulting in dif ... more
Single Molecule Spectroscopy of Amino Acids and Peptides by Recognition Tunneling
Stuart Lindsay, ASU Regents Professor, Director of the Biodesign Institute Center for Single Molecule Biophysics, Edward and Nadine Carson Presidential Chair in Physics more
The virulence of the Toxoplasma parasite identified
A research group led by Antonio Barragan of the Swedish Institute for Infectious Disease Control (SMI) and Karolinska Institutet (KI) has identified, with the help of colleagues from Washington University, the gene in the Toxoplasma parasite that accounts for its ability to cause disease. W ... more
Orion Genomics Announces Notice Of Allowance For US Patent Covering Genome Wide Novel Biomarker Discovery Platform
Orion Genomics announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent application that covers Orion's MethylScope technology, a broad approach to discovering and quantifying the DNA methylation status on each and every gene in the hum ... more
Mapping the spread of diarrhoea bacteria a major step towards new vaccine
Every year hundreds of thousands of people die from diarrhoeal diseases caused by ETEC bacteria. A study published in Nature Genetics describes how Swedish researchers have mapped the spread of strains of ETEC bacteria around the world. It provides key information about how pathogenic bacte ... more
Gene variant that dramatically reduces 'bad' lipids
Research using data collected from around 4,000 healthy people in the UK has enabled scientists to identify a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. The study is the first to emerge from the UK10K Project's cohort of samples from the g ... more
Elusive platelet count and limb development gene discovered
Researchers have identified an elusive gene responsible for Thrombocytopenia with Absent Radii (TAR), a rare inherited blood and skeletal disorder. As a result, this research is now being transformed into a medical test that allows prenatal diagnosis and genetic counselling in affected fami ... more
- 1Fingerprint breakthrough in breast cancer detection
- 2New method for the detection of RNA viruses such as SARS-CoV-2
- 3New organ-on-chip pilot seeks to reduce animal testing in consumer health industry
- 4How nanoplastics can influence metabolism
- 5Self-driven laboratory speeds chemical discovery
- 6Capturing nanoplastics in tap water with light
- 7Next generation solar fuels: How a record-breaking copper catalyst converts CO₂ into liquid fuels
- 8A further advance in super-resolution fluorescence microscopy
- 9New analysis method developed for nano and quantum materials
- 10Researchers uncover new water monitoring technique
- Graphene grows – and we can see it
- First comparative study on automated analysis methods of large data sets in ...
- Beethoven’s genome: New study reveals hereditary diseases and a family mystery
- Single-atom vibrational spectroscopy now sensitive at level of chemical bonds
- In search of the 'holy grail': researchers observe lithium ions in real time